
    
      Prospective, parallel group, two-arm, unblinded, international, cluster-randomized controlled
      trial.

      Intervention arm: A 16-week blended learning programme targeting stroke prevention and rhythm
      control therapy at the healthcare professional level, with controlled assessments, a
      commitment to change plan, and reinforcement actions Control arm: No added education of
      healthcare professionals 70 centres with a cluster size of 25 patients; total estimated
      number of patients 1750.

      8-12 weeks patient recruitment period at each centre; 16 weeks educational intervention
      period; primary & secondary outcomes at 6-9 months post-randomisation; remote follow-up for
      clinical events (no new patient contact) at 18 months from randomisation.
    
  